QUINCE THERAPEUTICS INC (QNCX)
US22053A1079 - Common Stock
ChartMill assigns a Buy % Consensus number of 43% to QNCX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 50.49. This target is 5214.74% above the current price.
QNCX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about QNCX.
In the previous month the buy percentage consensus was at a similar level.
QNCX was analyzed by 6 analysts. More opinions would make the average more meaningful.